Glatiramer Acetate
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2598 publications
Experimental Therapies in Multiple Sclerosis: Epstein-Barr Virus and Potential EBV-Related Therapeutic Strategies-A Systematic Review.
Journal: Journal of clinical medicine
Published: May 03, 2026
Industry Payments and Prescribing of Brand-Name Multiple Sclerosis Medications in Medicare.
Journal: Neurology
Published: April 06, 2026
Glatiramer Acetate Therapy Induces DNA Methylation Changes in Immune Cells of Multiple Sclerosis Patients: A Pilot Study.
Journal: International journal of molecular sciences
Published: April 02, 2026
Cumulative six-year safety outcomes of glatiramer acetate exposure during pregnancy and breastfeeding.
Journal: Journal of neurology
Published: March 25, 2026
Clinical, demographic, and pharmacological predictors of medication adherence to disease-modifying therapies in multiple sclerosis: a multidimensional analysis of merged survey and claims data.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: March 10, 2026
Pharmacogenomics of response to interferon-beta and glatiramer acetate in Multiple Sclerosis: A multi-centric study.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: March 03, 2026
GA Depot, a long-acting glatiramer acetate, vs placebo in patients with relapsing multiple sclerosis: A randomized phase 3 clinical trial.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: February 18, 2026
Identification of Drug Repurposing Opportunities of Immunomodulatory Drugs for Inflammatory Bowel Disease Through Inverse Pharmacovigilance Signal Detection in the FAERS Database.
Journal: Journal of clinical medicine
Published: February 01, 2026
Vimentin-NF-κB signaling contributing to IbeA-mediated adhesion, invasion, and biofilm formation during Escherichia coli K1 traversal of the blood-brain barrier.
Journal: Frontiers in immunology
Published: January 22, 2026
Comorbidities at MS Diagnosis and Their Association With Treatment Persistence: Real-World Clinical Data.
Journal: Brain and behavior
Published: January 05, 2026
The comparative efficacy of cladribine tablets versus alternative disease-modifying treatments for relapsing-remitting multiple sclerosis: Updated meta-regression estimates by patient subgroup.
Journal: Multiple sclerosis and related disorders
Published: December 20, 2025
Last Updated: 06/30/2026